Research: 90% of dampness allergies develop before age 5; seize the golden period to prevent it.
Skin allergies are a very common childhood skin problem that can begin in infancy or at any time. Studies indicate that 90% of children with skin allergies develop symptoms before the age of 5. Only about 10% of cases are diagnosed after age 5. Because skin allergies symptoms are recurrent, meaning they "come and go," some people's skin allergies persist into adulthood.
A recent study in the United States indicated that children are particularly susceptible to skin allergies, with symptoms appearing as early as 2 to 6 months of age. 90% of children with a predisposition to skin allergies develop them by age 5. Skin allergies are present in both boys and girls, but people of East Asian and African descent are at higher risk. Patients often have other health problems. Recent research suggests that the complex interactions between environment, genetics, skin barrier, and immune response are related to the development of skin allergies.
G-NiiB Immune Kids SIM03
It is a unique microbiome formula that can be used as a dietary supplement. This formula uses big data to select ideal naturally occurring live bacteria, with patented microencapsulated technology from Italy to enhance live bacteria survival and is clinically shown to be effective and safe in local children with sensitive skin. This formula is scientifically formulated with exclusive patent licensing and clinically studied by The Faculty of Medicine of a Renowned University in Hong Kong.
Studies have shown that the formula not only significantly reduced the infected area and intensity by 38.9% but also reduced the sensitivity index from moderate to mild in 100% of children with moderate eczema sensitivity and improved from severe to moderate in 50% of children with severe eczema sensitivity. The data confirms that the treatment effect increases over time, with the moderately sensitive skin group achieving comprehensive improvement and half of the severely sensitive skin group experiencing effective relief.
Purchase link:
https://g-niib.com/products/g-niib-immune-kids-sim03
References:
https://doi.org/10.1016/j.jaad.2013.10.010
https://doi.org/10.1111/j.1399-3038.2004.00160.x
https://doi.org/10.1016/j.clindermatol.2014.12.004
https://doi.org/10.1016/j.iac.2014.09.008
